145 related articles for article (PubMed ID: 37384873)
1. New Anthranilic Acid Hydrazones as Fenamate Isosteres: Synthesis, Characterization, Molecular Docking, Dynamics & in Silico ADME, in Vitro Anti-Inflammatory and Anticancer Activity Studies.
Şenol H; Çağman Z; Gençoğlu Katmerlikaya T; Sinan Tokalı F
Chem Biodivers; 2023 Aug; 20(8):e202300773. PubMed ID: 37384873
[TBL] [Abstract][Full Text] [Related]
2. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
3. Novel Hydrazone Derivatives of 3-Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies.
Beygi F; Mostoufi A; Mojaddami A
Chem Biodivers; 2022 Jun; 19(6):e202100754. PubMed ID: 35427437
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2-naphthoquinone thiosemicarbazones.
Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1192-8. PubMed ID: 22978426
[TBL] [Abstract][Full Text] [Related]
6. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2.
Shaker AMM; Shahin MI; AboulMagd AM; Abdel Aleem SA; Abdel-Rahman HM; Abou El Ella DA
Bioorg Chem; 2022 Dec; 129():106143. PubMed ID: 36191430
[TBL] [Abstract][Full Text] [Related]
7. New2-((2-(2,4-dinitrophenyl)hydrazineeylidene) derivatives: design, synthesis,
Sajjan VP; Anigol LB; Gurubasavaraj PM; Patil D; Patil PS; Gummagol NB; Quah CK; Wong QA; Celik I
J Biomol Struct Dyn; 2023; 41(21):11681-11699. PubMed ID: 36602778
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study.
Abdel-Aziz AA; El-Azab AS; AlSaif NA; Obaidullah AJ; Al-Obaid AM; Al-Suwaidan IA
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1521-1539. PubMed ID: 34266349
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Computational Analysis, Antimicrobial, Antioxidant, Trypan Blue Exclusion Assay, β-hematin Assay and Anti-inflammatory Studies of some Hydrazones (Part-I).
Mali SN; Pandey A
Curr Comput Aided Drug Des; 2023; 19(2):108-122. PubMed ID: 36177631
[TBL] [Abstract][Full Text] [Related]
10. Novel quinazoline-chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies.
Tokalı FS; Şenol H; Yetke Hİ; Hacıosmanoğlu-Aldoğan E
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300423. PubMed ID: 37736677
[TBL] [Abstract][Full Text] [Related]
11. New Niflumic Acid Derivatives as EGFR Inhibitors: Design, Synthesis,
Yaseen YS; Mahmood AAR; Abbas AH; Shihab WA; Tahtamouni LH
Med Chem; 2023; 19(5):445-459. PubMed ID: 36537605
[TBL] [Abstract][Full Text] [Related]
12. Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.
Tiwari MK; Coghi P; Agrawal P; Yadav DK; Yang LJ; Congling Q; Sahal D; Wai Wong VK; Chaudhary S
Eur J Med Chem; 2021 Nov; 224():113685. PubMed ID: 34303874
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors.
Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM
Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
15. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A
Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4-triazole containing hydrazide-hydrazones derived from (S)-naproxen.
Han MI; Bekçi H; Uba AI; Yıldırım Y; Karasulu E; Cumaoğlu A; Karasulu HY; Yelekçi K; Yılmaz Ö; Küçükgüzel ŞG
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800365. PubMed ID: 31115928
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, ADMET predictions, molecular docking studies, and
Sulistyowaty MI; Widyowati R; Putra GS; Budiati T; Matsunami K
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):385-392. PubMed ID: 34214332
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Cytotoxicity Evaluation and Molecular Docking of Fluorine Containing Hexahydroquinoline-3-Carbonitrile Derivatives.
Teraiya N; Karki SS; Chauhan A
Curr Drug Discov Technol; 2022; 19(1):e140122189603. PubMed ID: 33372877
[TBL] [Abstract][Full Text] [Related]
19. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and mechanistic studies of novel imidazo[1,2-a]pyridines as anticancer agents.
Ismael AS; Amin NH; Elsaadi MT; Abdel-Rahman HM
Bioorg Chem; 2022 Nov; 128():106042. PubMed ID: 35878430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
